サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：がん幹細胞療法の市場規模：タイプ別、がんタイプ別、エンドユーザー別、世界予測、2023年～2032年
市場調査レポート
商品コード
1389729

がん幹細胞療法の市場規模：タイプ別、がんタイプ別、エンドユーザー別、世界予測、2023年～2032年

Cancer Stem Cells Therapy Market Size - By Type (Targeted Cancer Stem Cells, Stem Cells-based), Cancer Type (Breast, Lung, Colorectal, Prostrate), End-user, Global Forecast (2023- 2032)
出版日: | 発行: Global Market Insights Inc. | ページ情報: 英文 120 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.11円
がん幹細胞療法の市場規模：タイプ別、がんタイプ別、エンドユーザー別、世界予測、2023年～2032年
出版日: 2023年10月25日
発行: Global Market Insights Inc.
ページ情報: 英文 120 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のがん幹細胞療法市場は、急成長する研究開発努力に後押しされ、2023年から2032年にかけて10.2％のCAGRを記録します。

革新的な治療薬や治療法に焦点を当てたこうした取り組みは、がんの複雑な核心を解明することを目的としています。例えば、2023年11月、ICMR-国立栄養研究所の専門家は、Genes &Diseases誌の中で、とらえどころのないがん幹細胞（CSCs）を標的とする非がん治療薬の再利用を提案しました。この戦略は、他の疾患に対して安全性が証明されている承認済みの薬剤を利用するもので、がん治療の革新への道をより安全かつ迅速に開くものです。CSCsは、腫瘍の攻撃性を決定し、標準的な治療に抵抗する上で極めて重要であり、よりカスタマイズされた治療法の必要性を強調しています。この画期的な発見は、オーダーメイドのがん治療への道を開くものです。

画期的な発見の熱烈な追求により、この分野はかつてない急成長を遂げ、標的療法と精密医療の需要を牽引しています。このような探索と革新の急増は、治療法の選択肢を広げるだけでなく、がん治療のパラダイムを変革する上でがん幹細胞療法市場の展望が重要な役割を果たすことを強調しています。

大腸がん分野は、2023年から2032年にかけて大きな発展を遂げると思われます。大腸がんはその有病率と課題から、がん幹細胞を標的とした革新的な治療法の必要性が強調されています。腫瘍の攻撃性と抵抗性におけるがん幹細胞の役割の複雑さが調査によって解明されるにつれて、市場は精密治療へのニーズの高まりに対応し、大腸がんへの対応におけるがん幹細胞療法市場の重要性を高めています。

専門センター分野は、2023年から2032年にかけて注目すべきCAGRを記録するでしょう。専門知識と最先端技術で名高いこれらのセンターは、がん幹細胞を標的とした革新的な治療法の需要を促進しています。これらの施設が新たなアプローチを開拓し、治療成績の向上を実証するにつれて、こうした専門的な治療に対する需要が急増し、がん幹細胞療法市場の展望を形成する上で専門センターが極めて重要な役割を果たしていることが浮き彫りになっています。

アジア太平洋地域のがん幹細胞療法産業は、2023年から2032年にかけて顕著なCAGRを示すと思われます。特に中国やインドのような国々では、がんの罹患率が上昇しており、がん幹細胞を標的とした革新的な治療法に対するニーズが高まっています。この地域での研究開発が拡大し、個別化医療への注目も相まって、市場はオーダーメイド治療への需要の急増を目の当たりにし、アジア太平洋におけるがん幹細胞療法の展望を形成しています。

例えば、2023年11月、和田春香准教授が率いる北海道大学遺伝子医学研究所による研究では、がん幹細胞がマウスモデルで免疫系を回避し、マクロファージの老化を引き起こすメカニズムが解明されました。これらの免疫細胞は通常、がん細胞死を引き起こすが、がん幹細胞の影響により老化が進むことが示されました。この発見は、『Journal for ImmunoTherapy of Cancer』誌に掲載されました。

目次

第1章 調査手法と調査範囲

第2章 エグゼクティブサマリー

第3章 がん幹細胞療法産業の洞察

  • 業界情勢、2018年～2032年
  • 業界への影響要因
    • 促進要因
      • がん患者の増加
      • 民間および公的イニシアチブの増加
      • 幹細胞治療に対する意識の高まり
      • 研究開発プログラムの増加
    • 業界の潜在的リスク＆課題
      • 関連する副作用
      • 幹細胞治療の高コスト
  • 成長可能性分析
  • COVID-19影響分析
  • 規制状況
  • ポーター分析
  • PESTEL分析

第4章 競合情勢

  • イントロダクション
  • 企業マトリックス分析
  • 主要市場プレーヤーの競合分析
  • 競合のポジショニングマトリックス
  • 戦略ダッシュボード

第5章 がん幹細胞療法の市場規模・予測：タイプ別、2018年～2032年

  • 主要動向：タイプ別
  • 標的がん幹細胞
  • 幹細胞ベース治療
    • 同種幹細胞
    • 自己幹細胞

第6章 がん幹細胞療法の市場規模・予測：がんタイプ別、2018年～2032年

  • 主要動向：がんタイプ別
  • 乳
  • 肺
  • 大腸
  • 前立腺
  • 胃
  • 肝臓
  • その他

第7章 がん幹細胞療法の市場規模・予測：エンドユーザー別、2018年～2032年

  • 主要動向：エンドユーザー別
  • 病院
  • 専門センター
  • その他

第8章 がん幹細胞療法の市場規模・予測：地域別、2018年～2032年

  • 主要動向：地域別
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • オーストラリア
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他ラテンアメリカ
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • その他中東・アフリカ

第9章 企業プロファイル

  • Gamida Cells
  • AbbVie Inc
  • Astellas Pharma Inc
  • Novadip Biosciences
  • ReNeuron Group plc
  • Celyad
  • Adna GmBH
  • Thermo Fisher Scientific
  • Genentech Inc
  • Merck KGaA
図表

Data Tables

  • TABLE 1 Market revenue, by type (2022)
  • TABLE 2 Market revenue, by cancer type (2022)
  • TABLE 3 Market revenue, by end-user (2022)
  • TABLE 4 Market share, by region (2022)
  • TABLE 5 Global cancer stem cells therapy market size, by region, 2018 - 2022 (USD Million)
  • TABLE 6 Global cancer stem cells therapy market size, by region, 2023 - 2032 (USD Million)
  • TABLE 7 Global cancer stem cells therapy market size, by type, 2018 - 2022 (USD Million)
  • TABLE 8 Global cancer stem cells therapy market size, by type, 2023 - 2032 (USD Million)
  • TABLE 9 Global cancer stem cells therapy market size, by cancer type, 2018 - 2022 (USD Million)
  • TABLE 10 Global cancer stem cells therapy market size, by cancer type, 2023 - 2032 (USD Million)
  • TABLE 11 Global cancer stem cells therapy market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 12 Global cancer stem cells therapy market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 13 Targeted cancer stem cells market size, 2018 - 2022 (USD Million)
  • TABLE 14 Targeted cancer stem cells market size, 2023 - 2032 (USD Million)
  • TABLE 15 Stem cells-based therapy market size, 2018 - 2022 (USD Million)
  • TABLE 16 Stem cells-based therapy market size, 2023 - 2032 (USD Million)
  • TABLE 17 Allogenic stem cell market size, 2018 - 2022 (USD Million)
  • TABLE 18 Allogenic stem cell market size, 2023 - 2032 (USD Million)
  • TABLE 19 Autologous stem cell market size, 2018 - 2022 (USD Million)
  • TABLE 20 Autologous stem cell market size, 2023 - 2032 (USD Million)
  • TABLE 21 Breast market size, 2018 - 2022 (USD Million)
  • TABLE 22 Breast market size, 2023 - 2032 (USD Million)
  • TABLE 23 Lung market size, 2018 - 2022 (USD Million)
  • TABLE 24 Lung market size, 2023 - 2032 (USD Million)
  • TABLE 25 Colorectal market size, 2018 - 2022 (USD Million)
  • TABLE 26 Colorectal market size, 2023 - 2032 (USD Million)
  • TABLE 27 Prostrate market size, 2018 - 2022 (USD Million)
  • TABLE 28 Prostrate market size, 2023 - 2032 (USD Million)
  • TABLE 29 Stomach market size, 2018 - 2022 (USD Million)
  • TABLE 30 Stomach market size, 2023 - 2032 (USD Million)
  • TABLE 31 Liver market size, 2018 - 2022 (USD Million)
  • TABLE 32 Liver market size, 2023 - 2032 (USD Million)
  • TABLE 33 Other cancer types market size, 2018 - 2022 (USD Million)
  • TABLE 34 Other cancer types market size, 2023 - 2032 (USD Million)
  • TABLE 35 Hospitals market size, 2018 - 2022 (USD Million)
  • TABLE 36 Hospitals market size, 2023 - 2032 (USD Million)
  • TABLE 37 Specialty centers market size, 2018 - 2022 (USD Million)
  • TABLE 38 Specialty centers market size, 2023 - 2032 (USD Million)
  • TABLE 39 Other end-users market size, 2018 - 2022 (USD Million)
  • TABLE 40 Other end-users market size, 2023 - 2032 (USD Million)
  • TABLE 41 North America cancer stem cells therapy market size, by country, 2018 - 2022 (USD Million)
  • TABLE 42 North America cancer stem cells therapy market size, by country, 2023 - 2032 (USD Million)
  • TABLE 43 North America cancer stem cells therapy market size, by type, 2018- 2022 (USD Million)
  • TABLE 44 North America cancer stem cells therapy market size, by type, 2023- 2032 (USD Million)
  • TABLE 45 North America cancer stem cells therapy market size, by stem cells-based therapy, 2018- 2022 (USD Million)
  • TABLE 46 North America cancer stem cells therapy market size, by stem cells-based therapy, 2023- 2032 (USD Million)
  • TABLE 47 North America cancer stem cells therapy market size, by cancer type, 2018 - 2022 (USD Million)
  • TABLE 48 North America cancer stem cells therapy market size, by cancer type, 2023 - 2032 (USD Million)
  • TABLE 49 North America cancer stem cells therapy market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 50 North America cancer stem cells therapy market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 51 U.S. cancer stem cells therapy market size, by type, 2018- 2022 (USD Million)
  • TABLE 52 U.S. cancer stem cells therapy market size, by type, 2023- 2032 (USD Million)
  • TABLE 53 U.S. cancer stem cells therapy market size, by stem cells-based therapy, 2018- 2022 (USD Million)
  • TABLE 54 U.S. cancer stem cells therapy market size, by stem cells-based therapy, 2023- 2032 (USD Million)
  • TABLE 55 U.S. cancer stem cells therapy market size, by cancer type, 2018 - 2022 (USD Million)
  • TABLE 56 U.S. cancer stem cells therapy market size, by cancer type, 2023 - 2032 (USD Million)
  • TABLE 57 U.S. cancer stem cells therapy market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 58 U.S. cancer stem cells therapy market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 59 Canada cancer stem cells therapy market size, by type, 2018- 2022 (USD Million)
  • TABLE 60 Canada cancer stem cells therapy market size, by type, 2023- 2032 (USD Million)
  • TABLE 61 Canada cancer stem cells therapy market size, by stem cells-based therapy, 2018- 2022 (USD Million)
  • TABLE 62 Canada cancer stem cells therapy market size, by stem cells-based therapy, 2023- 2032 (USD Million)
  • TABLE 63 Canada cancer stem cells therapy market size, by cancer type, 2018 - 2022 (USD Million)
  • TABLE 64 Canada cancer stem cells therapy market size, by cancer type, 2023 - 2032 (USD Million)
  • TABLE 65 Canada cancer stem cells therapy market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 66 Canada cancer stem cells therapy market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 67 Europe cancer stem cells therapy market size, by country, 2018 - 2022 (USD Million)
  • TABLE 68 Europe cancer stem cells therapy market size, by country, 2023 - 2032 (USD Million)
  • TABLE 69 Europe cancer stem cells therapy market size, by type, 2018- 2022 (USD Million)
  • TABLE 70 Europe cancer stem cells therapy market size, by type, 2023- 2032 (USD Million)
  • TABLE 71 Europe cancer stem cells therapy market size, by stem cells-based therapy, 2018- 2022 (USD Million)
  • TABLE 72 Europe cancer stem cells therapy market size, by stem cells-based therapy, 2023- 2032 (USD Million)
  • TABLE 73 Europe cancer stem cells therapy market size, by cancer type, 2018 - 2022 (USD Million)
  • TABLE 74 Europe cancer stem cells therapy market size, by cancer type, 2023 - 2032 (USD Million)
  • TABLE 75 Europe cancer stem cells therapy market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 76 Europe cancer stem cells therapy market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 77 Germany cancer stem cells therapy market size, by type, 2018- 2022 (USD Million)
  • TABLE 78 Germany cancer stem cells therapy market size, by type, 2025- 2032 (USD Million)
  • TABLE 79 Germany cancer stem cells therapy market size, by stem cells-based therapy, 2018- 2022 (USD Million)
  • TABLE 80 Germany cancer stem cells therapy market size, by stem cells-based therapy, 2025- 2032 (USD Million)
  • TABLE 81 Germany cancer stem cells therapy market size, by cancer type, 2018 - 2022 (USD Million)
  • TABLE 82 Germany cancer stem cells therapy market size, by cancer type, 2023 - 2032 (USD Million)
  • TABLE 83 Germany cancer stem cells therapy market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 84 Germany cancer stem cells therapy market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 85 UK cancer stem cells therapy market size, by type, 2018- 2024 (USD Million)
  • TABLE 86 UK cancer stem cells therapy market size, by type, 2025- 2032 (USD Million)
  • TABLE 87 UK cancer stem cells therapy market size, by stem cells-based therapy, 2018- 2023 (USD Million)
  • TABLE 88 UK cancer stem cells therapy market size, by stem cells-based therapy, 2023- 2032 (USD Million)
  • TABLE 89 UK cancer stem cells therapy market size, by cancer type, 2018 - 2022 (USD Million)
  • TABLE 90 UK cancer stem cells therapy market size, by cancer type, 2023 - 2032 (USD Million)
  • TABLE 91 UK cancer stem cells therapy market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 92 UK cancer stem cells therapy market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 93 France cancer stem cells therapy market size, by type, 2018- 2022 (USD Million)
  • TABLE 94 France cancer stem cells therapy market size, by type, 2023- 2032 (USD Million)
  • TABLE 95 France cancer stem cells therapy market size, by stem cells-based therapy, 2018- 2022 (USD Million)
  • TABLE 96 France cancer stem cells therapy market size, by stem cells-based therapy, 2023- 2032 (USD Million)
  • TABLE 97 France cancer stem cells therapy market size, by cancer type, 2018 - 2022 (USD Million)
  • TABLE 98 France cancer stem cells therapy market size, by cancer type, 2023 - 2032 (USD Million)
  • TABLE 99 France cancer stem cells therapy market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 100 France cancer stem cells therapy market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 101 Italy cancer stem cells therapy market size, by type, 2018- 2022 (USD Million)
  • TABLE 102 Italy cancer stem cells therapy market size, by type, 2025- 2032 (USD Million)
  • TABLE 103 Italy cancer stem cells therapy market size, by stem cells-based therapy, 2018- 2022 (USD Million)
  • TABLE 104 Italy cancer stem cells therapy market size, by stem cells-based therapy, 2023- 2032 (USD Million)
  • TABLE 105 Italy cancer stem cells therapy market size, by cancer type, 2018 - 2022 (USD Million)
  • TABLE 106 Italy cancer stem cells therapy market size, by cancer type, 2023 - 2032 (USD Million)
  • TABLE 107 Italy cancer stem cells therapy market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 108 Italy cancer stem cells therapy market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 109 Spain cancer stem cells therapy market size, by type, 2018- 2022 (USD Million)
  • TABLE 110 Spain cancer stem cells therapy market size, by type, 2023- 2032 (USD Million)
  • TABLE 111 Spain cancer stem cells therapy market size, by stem cells-based therapy, 2018- 2022 (USD Million)
  • TABLE 112 Spain cancer stem cells therapy market size, by stem cells-based therapy, 2023- 2032 (USD Million)
  • TABLE 113 Spain cancer stem cells therapy market size, by cancer type, 2018 - 2022 (USD Million)
  • TABLE 114 Spain cancer stem cells therapy market size, by cancer type, 2023 - 2032 (USD Million)
  • TABLE 115 Spain cancer stem cells therapy market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 116 Spain cancer stem cells therapy market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 117 Rest of Europe cancer stem cells therapy market size, by type, 2018- 2022 (USD Million)
  • TABLE 118 Rest of Europe cancer stem cells therapy market size, by type, 2023- 2032 (USD Million)
  • TABLE 119 Rest of Europe cancer stem cells therapy market size, by stem cells-based therapy, 2018- 2022 (USD Million)
  • TABLE 120 Rest of Europe cancer stem cells therapy market size, by stem cells-based therapy, 2023- 2032 (USD Million)
  • TABLE 121 Rest of Europe cancer stem cells therapy market size, by cancer type, 2018 - 2022 (USD Million)
  • TABLE 122 Rest of Europe cancer stem cells therapy market size, by cancer type, 2023 - 2032 (USD Million)
  • TABLE 123 Rest of Europe cancer stem cells therapy market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 124 Rest of Europe cancer stem cells therapy market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 125 Asia Pacific cancer stem cells therapy market size, by country, 2018 - 2022 (USD Million)
  • TABLE 126 Asia Pacific cancer stem cells therapy market size, by country, 2023 - 2032 (USD Million)
  • TABLE 127 Asia Pacific cancer stem cells therapy market size, by type, 2018- 2022 (USD Million)
  • TABLE 128 Asia Pacific cancer stem cells therapy market size, by type, 2023- 2032 (USD Million)
  • TABLE 129 Asia Pacific cancer stem cells therapy market size, by stem cells-based therapy, 2018- 2022 (USD Million)
  • TABLE 130 Asia Pacific cancer stem cells therapy market size, by stem cells-based therapy, 2023- 2032 (USD Million)
  • TABLE 131 Asia Pacific cancer stem cells therapy market size, by cancer type, 2018 - 2022 (USD Million)
  • TABLE 132 Asia Pacific cancer stem cells therapy market size, by cancer type, 2023 - 2032 (USD Million)
  • TABLE 133 Asia Pacific cancer stem cells therapy market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 134 Asia Pacific cancer stem cells therapy market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 135 China cancer stem cells therapy market size, by type, 2018- 2022 (USD Million)
  • TABLE 136 China cancer stem cells therapy market size, by type, 2023- 2032 (USD Million)
  • TABLE 137 China cancer stem cells therapy market size, by stem cells-based therapy, 2018- 2022 (USD Million)
  • TABLE 138 China cancer stem cells therapy market size, by stem cells-based therapy, 2023- 2032 (USD Million)
  • TABLE 139 China cancer stem cells therapy market size, by cancer type, 2018 - 2022 (USD Million)
  • TABLE 140 China cancer stem cells therapy market size, by cancer type, 2023 - 2032 (USD Million)
  • TABLE 141 China cancer stem cells therapy market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 142 China cancer stem cells therapy market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 143 Japan cancer stem cells therapy market size, by type, 2018- 2022 (USD Million)
  • TABLE 144 Japan cancer stem cells therapy market size, by type, 2023- 2032 (USD Million)
  • TABLE 145 Japan cancer stem cells therapy market size, by stem cells-based therapy, 2018- 2022 (USD Million)
  • TABLE 146 Japan cancer stem cells therapy market size, by stem cells-based therapy, 2023- 2032 (USD Million)
  • TABLE 147 Japan cancer stem cells therapy market size, by cancer type, 2018 - 2022 (USD Million)
  • TABLE 148 Japan cancer stem cells therapy market size, by cancer type, 2023 - 2032 (USD Million)
  • TABLE 149 Japan cancer stem cells therapy market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 150 Japan cancer stem cells therapy market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 151 India cancer stem cells therapy market size, by type, 2018- 2022 (USD Million)
  • TABLE 152 India cancer stem cells therapy market size, by type, 2023- 2032 (USD Million)
  • TABLE 153 India cancer stem cells therapy market size, by stem cells-based therapy, 2018- 2022 (USD Million)
  • TABLE 154 India cancer stem cells therapy market size, by stem cells-based therapy, 2023- 2032 (USD Million)
  • TABLE 155 India cancer stem cells therapy market size, by cancer type, 2018 - 2022 (USD Million)
  • TABLE 156 India cancer stem cells therapy market size, by cancer type, 2023 - 2032 (USD Million)
  • TABLE 157 India cancer stem cells therapy market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 158 India cancer stem cells therapy market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 159 Australia cancer stem cells therapy market size, by type, 2018- 2022 (USD Million)
  • TABLE 160 Australia cancer stem cells therapy market size, by type, 2023- 2032 (USD Million)
  • TABLE 161 Australia cancer stem cells therapy market size, by stem cells-based therapy, 2018- 2022 (USD Million)
  • TABLE 162 Australia cancer stem cells therapy market size, by stem cells-based therapy, 2023- 2032 (USD Million)
  • TABLE 163 Australia cancer stem cells therapy market size, by cancer type, 2018 - 2022 (USD Million)
  • TABLE 164 Australia cancer stem cells therapy market size, by cancer type, 2023 - 2032 (USD Million)
  • TABLE 165 Australia cancer stem cells therapy market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 166 Australia cancer stem cells therapy market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 167 Rest of Asia Pacific cancer stem cells therapy market size, by type, 2018- 2022 (USD Million)
  • TABLE 168 Rest of Asia Pacific cancer stem cells therapy market size, by type, 2023- 2032 (USD Million)
  • TABLE 169 Rest of Asia Pacific cancer stem cells therapy market size, by stem cells-based therapy, 2018- 2022 (USD Million)
  • TABLE 170 Rest of Asia Pacific cancer stem cells therapy market size, by stem cells-based therapy, 2023- 2032 (USD Million)
  • TABLE 171 Rest of Asia Pacific cancer stem cells therapy market size, by cancer type, 2018 - 2022 (USD Million)
  • TABLE 172 Rest of Asia Pacific cancer stem cells therapy market size, by cancer type, 2023 - 2032 (USD Million)
  • TABLE 173 Rest of Asia Pacific cancer stem cells therapy market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 174 Rest of Asia Pacific cancer stem cells therapy market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 175 Latin America cancer stem cells therapy market size, by country, 2018 - 2022 (USD Million)
  • TABLE 176 Latin America cancer stem cells therapy market size, by country, 2023 - 2032 (USD Million)
  • TABLE 177 Latin America cancer stem cells therapy market size, by type, 2018- 2022 (USD Million)
  • TABLE 178 Latin America cancer stem cells therapy market size, by type, 2023- 2032 (USD Million)
  • TABLE 179 Latin America cancer stem cells therapy market size, by stem cells-based therapy, 2018- 2022 (USD Million)
  • TABLE 180 Latin America cancer stem cells therapy market size, by stem cells-based therapy, 2023- 2032 (USD Million)
  • TABLE 181 Latin America cancer stem cells therapy market size, by cancer type, 2018 - 2022 (USD Million)
  • TABLE 182 Latin America cancer stem cells therapy market size, by cancer type, 2023 - 2032 (USD Million)
  • TABLE 183 Latin America cancer stem cells therapy market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 184 Latin America cancer stem cells therapy market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 185 Brazil cancer stem cells therapy market size, by type, 2018- 2022 (USD Million)
  • TABLE 186 Brazil cancer stem cells therapy market size, by type, 2023- 2032 (USD Million)
  • TABLE 187 Brazil cancer stem cells therapy market size, by stem cells-based therapy, 2018- 2022 (USD Million)
  • TABLE 188 Brazil cancer stem cells therapy market size, by stem cells-based therapy, 2023- 2032 (USD Million)
  • TABLE 189 Brazil cancer stem cells therapy market size, by cancer type, 2018 - 2022 (USD Million)
  • TABLE 190 Brazil cancer stem cells therapy market size, by cancer type, 2023 - 2032 (USD Million)
  • TABLE 191 Brazil cancer stem cells therapy market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 192 Brazil cancer stem cells therapy market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 193 Mexico cancer stem cells therapy market size, by type, 2018- 2022 (USD Million)
  • TABLE 194 Mexico cancer stem cells therapy market size, by type, 2023- 2032 (USD Million)
  • TABLE 195 Mexico cancer stem cells therapy market size, by stem cells-based therapy, 2018- 2022 (USD Million)
  • TABLE 196 Mexico cancer stem cells therapy market size, by stem cells-based therapy, 2023- 2032 (USD Million)
  • TABLE 197 Mexico cancer stem cells therapy market size, by cancer type, 2018 - 2022 (USD Million)
  • TABLE 198 Mexico cancer stem cells therapy market size, by cancer type, 2023 - 2032 (USD Million)
  • TABLE 199 Mexico cancer stem cells therapy market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 200 Mexico cancer stem cells therapy market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 201 Rest of Latin America cancer stem cells therapy market size, by type, 2018- 2022 (USD Million)
  • TABLE 202 Rest of Latin America cancer stem cells therapy market size, by type, 2023- 2032 (USD Million)
  • TABLE 203 Rest of Latin America cancer stem cells therapy market size, by stem cells-based therapy, 2018- 2022 (USD Million)
  • TABLE 204 Rest of Latin America cancer stem cells therapy market size, by stem cells-based therapy, 2023- 2032 (USD Million)
  • TABLE 205 Rest of Latin America cancer stem cells therapy market size, by cancer type, 2018 - 2022 (USD Million)
  • TABLE 206 Rest of Latin America cancer stem cells therapy market size, by cancer type, 2023 - 2032 (USD Million)
  • TABLE 207 Rest of Latin America cancer stem cells therapy market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 208 Rest of Latin America cancer stem cells therapy market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 209 Middle East & Africa cancer stem cells therapy market size, by country, 2018 - 2022 (USD Million)
  • TABLE 210 Middle East & Africa cancer stem cells therapy market size, by country, 2023 - 2032 (USD Million)
  • TABLE 211 Middle East & Africa cancer stem cells therapy market size, by type, 2018- 2022 (USD Million)
  • TABLE 212 Middle East & Africa cancer stem cells therapy market size, by type, 2023- 2032 (USD Million)
  • TABLE 213 Middle East & Africa cancer stem cells therapy market size, by stem cells-based therapy, 2018- 2022 (USD Million)
  • TABLE 214 Middle East & Africa cancer stem cells therapy market size, by stem cells-based therapy, 2023- 2032 (USD Million)
  • TABLE 215 Middle East & Africa cancer stem cells therapy market size, by cancer type, 2018 - 2022 (USD Million)
  • TABLE 216 Middle East & Africa cancer stem cells therapy market size, by cancer type, 2023 - 2032 (USD Million)
  • TABLE 217 Middle East & Africa cancer stem cells therapy market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 218 Middle East & Africa cancer stem cells therapy market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 219 South Africa cancer stem cells therapy market size, by type, 2018- 2022 (USD Million)
  • TABLE 220 South Africa cancer stem cells therapy market size, by type, 2023- 2032 (USD Million)
  • TABLE 221 South Africa cancer stem cells therapy market size, by stem cells-based therapy, 2018- 2022 (USD Million)
  • TABLE 222 South Africa cancer stem cells therapy market size, by stem cells-based therapy, 2023- 2032 (USD Million)
  • TABLE 223 South Africa cancer stem cells therapy market size, by cancer type, 2018 - 2022 (USD Million)
  • TABLE 224 South Africa cancer stem cells therapy market size, by cancer type, 2023 - 2032 (USD Million)
  • TABLE 225 South Africa cancer stem cells therapy market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 226 South Africa cancer stem cells therapy market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 227 Saudi Arabia cancer stem cells therapy market size, by type, 2018- 2022 (USD Million)
  • TABLE 228 Saudi Arabia cancer stem cells therapy market size, by type, 2023- 2032 (USD Million)
  • TABLE 229 Saudi Arabia cancer stem cells therapy market size, by stem cells-based therapy, 2018- 2022 (USD Million)
  • TABLE 230 Saudi Arabia cancer stem cells therapy market size, by stem cells-based therapy, 2023- 2032 (USD Million)
  • TABLE 231 Saudi Arabia cancer stem cells therapy market size, by cancer type, 2018 - 2022 (USD Million)
  • TABLE 232 Saudi Arabia cancer stem cells therapy market size, by cancer type, 2023 - 2032 (USD Million)
  • TABLE 233 Saudi Arabia cancer stem cells therapy market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 234 Saudi Arabia cancer stem cells therapy market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 235 Rest of Middle East & Africa cancer stem cells therapy market size, by type, 2018- 2022 (USD Million)
  • TABLE 236 Rest of Middle East & Africa cancer stem cells therapy market size, by type, 2023- 2032 (USD Million)
  • TABLE 237 Rest of Middle East & Africa cancer stem cells therapy market size, by stem cells-based therapy, 2018- 2022 (USD Million)
  • TABLE 238 Rest of Middle East & Africa cancer stem cells therapy market size, by stem cells-based therapy, 2023- 2032 (USD Million)
  • TABLE 239 Rest of Middle East & Africa cancer stem cells therapy market size, by cancer type, 2018 - 2022 (USD Million)
  • TABLE 240 Rest of Middle East & Africa cancer stem cells therapy market size, by cancer type, 2023 - 2032 (USD Million)
  • TABLE 241 Rest of Middle East & Africa cancer stem cells therapy market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 242 Rest of Middle East & Africa cancer stem cells therapy market size, by end-user, 2023 - 2032 (USD Million)

Charts & Figures

  • FIG 1 GMI report coverage: Critical research elements
  • FIG 2 Top-down approach
  • FIG 3 Market estimation and forecast methodology
  • FIG 4 Market forecasting methodology
  • FIG 5 Breakdown of primary participants
  • FIG 6 Cancer stem cells therapy industry 360 degree synopsis, 2018 - 2032
  • FIG 7 Growth potential analysis, by type
  • FIG 8 Growth potential analysis, by cancer type
  • FIG 9 Growth potential analysis, by end-user
  • FIG 10 Porter's analysis
  • FIG 11 PESTEL analysis
  • FIG 12 Company matrix analysis, 202
  • FIG 13 Competitive analysis of major market players, 2022
  • FIG 14 Competitive positioning matrix
目次
Product Code: 7152

Global Cancer Stem Cells Therapy Market will witness 10.2% CAGR between 2023 and 2032, propelled by burgeoning research and development endeavors. These efforts, focusing on innovative therapeutics and treatments, aim to unravel the complexities of cancer at its core. For instance, in November 2023, in a Genes & Diseases review, ICMR-National Institute of Nutrition experts proposed the repurposing of non-cancer drugs to target elusive cancer stem cells (CSCs). This strategy taps into approved drugs with proven safety for other conditions, offering a safer and quicker path to innovate cancer therapy. CSCs, crucial in determining tumor aggressiveness and resisting standard treatments, underscore the need for more customized therapies. This breakthrough paves the way for tailored cancer treatments.

With an ardent pursuit of breakthrough discoveries, the field witnesses an unprecedented surge, driving the demand for targeted therapies and precision medicine. This surge in exploration and innovation not only amplifies therapeutic options but also underscores the critical role of the cancer stem cells therapy market outlook in revolutionizing cancer treatment paradigms.

The overall Cancer Stem Cells Therapy Market is classified based on cancer type, end-user, and region.

Colorectal cancer segment will undergo significant development from 2023 to 2032. With its prevalence and challenging nature, colorectal cancer underscores the necessity for innovative therapies targeting cancer stem cells. As research unravels the intricacies of these cells' role in tumor aggressiveness and resistance, the market responds with a growing need for precision therapies, elevating the significance of cancer stem cells therapy market share in addressing colorectal cancer.

Specialty centers segment will register a noteworthy CAGR from 2023 to 2032. These centers, renowned for their expertise and cutting-edge technology, fuel the demand for innovative therapies targeting cancer stem cells. As they pioneer new approaches and demonstrate improved outcomes, the market witnesses a surge in demand for these specialized treatments, highlighting the pivotal role of specialty centers in shaping the cancer stem cells therapy market outlook.

Asia Pacific cancer stem cells therapy industry will showcase a commendable CAGR from 2023 to 2032. With a rising prevalence of cancer, especially in countries like China and India, there's a growing need for innovative therapies targeting cancer stem cells. As research and development expand in this region, coupled with a focus on personalized medicine, the market witnesses a surge in demand for tailored treatments, shaping the cancer stem cells therapy landscape in Asia-Pacific.

For instance, in November 2023, a study by Hokkaido University's Institute for Genetic Medicine, led by Associate Professor Haruka Wada, delved into how cancer stem cells evade the immune system in mouse models, triggering aging in macrophages. These immune cells typically initiate cancer cell death but were shown to undergo senescence due to the influence of cancer stem cells. The Journal for ImmunoTherapy of Cancer published their discoveries.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market definition
  • 1.2 Base estimates & calculations
  • 1.3 Forecast calculation
  • 1.4 Covid-19 impact analysis at global level
  • 1.5 Data validation
  • 1.6 Data sources
    • 1.6.1 Primary
    • 1.6.2 Secondary
      • 1.6.2.1 Paid sources
      • 1.6.2.2 Unpaid sources

Chapter 2 Executive Summary

  • 2.1 Global cancer stem cells therapy market 360 degree synopsis, 2018 - 2032
  • 2.2 Business trends
  • 2.3 Region trends
  • 2.4 Type trends
  • 2.5 Cancer type trends
  • 2.6 End-user trends

Chapter 3 Cancer Stem Cells Therapy Industry Insights

  • 3.1 Industry landscape, 2018 - 2032 (USD Million)
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing cases of cancer
      • 3.2.1.2 Increasing private and public initiatives
      • 3.2.1.3 Rising awareness regarding availability of stem cell therapy
      • 3.2.1.4 Increasing research & development programs
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Associated side-effects
      • 3.2.2.2 High cost of stem cell therapy
  • 3.3 Growth potential analysis
    • 3.3.1 By type
    • 3.3.2 By cancer type
    • 3.3.3 By end-user
  • 3.4 COVID-19 impact analysis
  • 3.5 Regulatory landscape
  • 3.6 Porter's analysis
  • 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

  • 4.1 Introduction
  • 4.2 Company matrix analysis, 2022
  • 4.3 Competitive analysis of major market players,
  • 4.4 Competitive positioning matrix, 2022
  • 4.5 Strategic dashboard, 2022

Chapter 5 Cancer Stem Cells Therapy Market Size and Forecast, By Type, 2018-2032 (USD Million)

  • 5.1 Key trends, by type
  • 5.2 Targeted cancer stem cells
  • 5.3 Stem cells-based therapy
    • 5.3.1 Allogenic stem cell
    • 5.3.2 Autologous stem cell

Chapter 6 Cancer Stem Cells Therapy Market Size and Forecast, By Cancer Type 2018-2032 (USD Million)

  • 6.1 Key trends, by cancer type
  • 6.2 Breast
  • 6.3 Lung
  • 6.4 Colorectal
  • 6.5 Prostrate
  • 6.6 Stomach
  • 6.7 Liver
  • 6.8 Other cancer types

Chapter 7 Cancer Stem Cells Therapy Market Size and Forecast, By End-user, 2018-2032 (USD Million)

  • 7.1 Key trends, by end-user
  • 7.2 Hospitals
  • 7.3 Specialty centres
  • 7.4 Other end-users

Chapter 8 Cancer Stem Cells Therapy Market Size and Forecast, By Region, 2018-2032 (USD Million)

  • 8.1 Key trends, by region
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Italy
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Rest of Latin America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 South Africa
    • 8.6.3 Rest of Middle East & Africa

Chapter 9 Company Profiles

  • 9.1 Gamida Cells
  • 9.2 AbbVie Inc
  • 9.3 Astellas Pharma Inc
  • 9.4 Novadip Biosciences
  • 9.5 ReNeuron Group plc
  • 9.6 Celyad
  • 9.7 Adna GmBH
  • 9.8 Thermo Fisher Scientific
  • 9.9 Genentech Inc
  • 9.10 Merck KGaA